Literature DB >> 21046258

Quality of life and depressive symptoms in Chagas disease patients.

Yaeko Ozaki1, Maria Elena Guariento, Eros Antonio de Almeida.   

Abstract

BACKGROUND: Besides the typical organic aspects of Chagas disease, the patients need to face physical, psychological, social and economic difficulties, which can compromise their quality of life. Consequently they may develop feelings of sadness, grief and loss, and depressive symptoms.
METHODS: This study assessed the quality of life and depressive symptoms in 110 Chagas disease patients using WHOQOL-BREF for measuring the quality of life; also it was used Beck Depression Inventory (BDI) for depressive symptom evaluation.
RESULTS: Among all patients, 51% were women; 42.5% considered their quality of life as positive and 40.9% presented depressive symptoms. Chagas disease clinical form distribution was: cardiac 49.09%, indeterminate 26.36%, digestive 12.73%, and mixed 11.82%. There was no significant difference comparing the depressive symptom intensity on gender, age and marital status, although there was a significant difference comparing depressive symptoms in indeterminate clinical form patients with others. All domains of WHOQOL-BREF showed significant correlation coefficients (Pearson).
CONCLUSIONS: At digestive form it was reported minor scores in the quality of life domains and greater ones on depressive symptom levels. There was a negative correlation between BDI and WHOQOL-BREF, suggesting that, among Chagas disease patients, the higher is the quality of life the lower is the intensity of depressive symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 21046258     DOI: 10.1007/s11136-010-9726-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

1.  [The ACHEI Program: Chagas' disease awareness through comprehensive education in the municipality of Maringá, Northwest Paraná, Brazil].

Authors:  S M de Araújo; M H Andó; D J Cassarotti; D C Mota; S M Borges; M L Gomes
Journal:  Rev Soc Bras Med Trop       Date:  2000 Nov-Dec       Impact factor: 1.581

2.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.

Authors:  Kelly C Dourado; Reinaldo B Bestetti; José A Cordeiro; Tatiana A Theodoropoulos
Journal:  Int J Cardiol       Date:  2006-04-14       Impact factor: 4.164

4.  Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale.

Authors:  Cláudia Débora Silberman; Jerson Laks; Cláudia Figueiredo Capitão; Cláudia Soares Rodrigues; Irene Moreira; Eliasz Engelhardt
Journal:  Arq Neuropsiquiatr       Date:  2006-06       Impact factor: 1.420

5.  The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients.

Authors:  Letícia M Furlanetto; Mauro V Mendlowicz; J Romildo Bueno
Journal:  J Affect Disord       Date:  2005-05       Impact factor: 4.839

6.  [Depression and Acute Coronary Syndromes: gender-related differences].

Authors:  Glória Heloise Perez; José Carlos Nicolau; Bellkiss Wilma Romano; Ronaldo Laranjeira
Journal:  Arq Bras Cardiol       Date:  2005-12-05       Impact factor: 2.000

7.  [Awareness of cancer diagnosis does not lead to depression in palliative care patients].

Authors:  Renata Wanderley Diniz; Marina Sahade Gonçalves; Carolina Games Bensi; Arinilda Silva Campos; Auro Del Giglio; Juliana Bueno Garcia; Vanessa da Costa Miranda; Tatiana Alves Monteiro; Michelle Rosemberg
Journal:  Rev Assoc Med Bras (1992)       Date:  2006 Sep-Oct       Impact factor: 1.209

Review 8.  [Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)].

Authors:  Marcelo Pio de Almeida Fleck; Beny Lafer; Everton Botelho Sougey; José Alberto Del Porto; Marco Antônio Brasil; Mário Francisco Juruena
Journal:  Braz J Psychiatry       Date:  2003-06       Impact factor: 2.697

9.  Postoperative complications in the treatment of chagasic megaesophagus.

Authors:  P Martins; B B Morais; J R Cunha-Melo
Journal:  Int Surg       Date:  1993 Apr-Jun

10.  All-around care for patients with Chagas disease: a challenge for the XXI century.

Authors:  Wilson de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

View more
  17 in total

1.  The prognostic value of health-related quality of life in patients with Chagas heart disease.

Authors:  Henrique Silveira Costa; Márcia Maria Oliveira Lima; Pedro Henrique Scheidt Figueiredo; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otávio da Costa Rocha
Journal:  Qual Life Res       Date:  2018-08-30       Impact factor: 4.147

2.  Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.

Authors:  Solange L de Castro; Denise G J Batista; Marcos M Batista; Wanderson Batista; Anissa Daliry; Elen M de Souza; Rubem F S Menna-Barreto; Gabriel M Oliveira; Kelly Salomão; Cristiane F Silva; Patricia B Silva; Maria de Nazaré C Soeiro
Journal:  Mol Biol Int       Date:  2011-06-30

3.  "I Cannot Be Worried": Living with Chagas Disease in Tropical Bolivia.

Authors:  Colin J Forsyth
Journal:  PLoS Negl Trop Dis       Date:  2017-01-18

4.  Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project.

Authors:  Nayara Dornela Quintino; Ester Cerdeira Sabino; José Luiz Padilha da Silva; Antonio Luiz Pinho Ribeiro; Ariela Mota Ferreira; Gabriela Lemes Davi; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso
Journal:  PLoS Negl Trop Dis       Date:  2020-05-27

5.  Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia.

Authors:  Libardo J Gómez; Robin van Wijk; Lena van Selm; Alberto Rivera; Martha C Barbosa; Sandra Parisi; Wim H van Brakel; Jofren Arevalo; William Quintero; Mitzi Waltz; Karl Philipp Puchner
Journal:  Trans R Soc Trop Med Hyg       Date:  2020-07-01       Impact factor: 2.184

6.  Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis.

Authors:  Celina Borges Migliavaca; Cinara Stein; Verônica Colpani; Sandro René Pinto de Sousa Miguel; Luciane Nascimento Cruz; Roberto Oliveira Dantas; Maicon Falavigna
Journal:  PLoS Negl Trop Dis       Date:  2018-09-28

Review 7.  Quality of life in patients with Chagas disease and the instrument used: an integrative review.

Authors:  Nayara Ragi Baldoni; Nayara Dornela Quintino; Geisa Cristina Silva Alves; Claudia Di Lorenzo Oliveira; Ester Cerdeira Sabino; Antonio Luiz Pinho Ribeiro; Clareci Silva Cardoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-06-18       Impact factor: 2.169

8.  Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease.

Authors:  Glaucia Vilar-Pereira; Leonardo Alexandre de Souza Ruivo; Joseli Lannes-Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

Review 9.  WHF IASC Roadmap on Chagas Disease.

Authors:  Luis Eduardo Echeverría; Rachel Marcus; Gabriel Novick; Sergio Sosa-Estani; Kate Ralston; Ezequiel Jose Zaidel; Colin Forsyth; Antonio Luiz P RIbeiro; Iván Mendoza; Mariano Luis Falconi; Jorge Mitelman; Carlos A Morillo; Ana Cristina Pereiro; María Jesús Pinazo; Roberto Salvatella; Felipe Martinez; Pablo Perel; Álvaro Sosa Liprandi; Daniel José Piñeiro; Gustavo Restrepo Molina
Journal:  Glob Heart       Date:  2020-03-30

10.  Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease.

Authors:  Robin van Wijk; Lena van Selm; Martha C Barbosa; Wim H van Brakel; Mitzi Waltz; Karl Philipp Puchner
Journal:  Glob Ment Health (Camb)       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.